glp-1/glucagon dual receptor agonist Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Agonists: A Scoping Review LY3437943, a novel triple glucagon,

Can GLP-1 be used in type 1 diabetes

Our goal here is to unpack the science, look at the potential pathways, and provide a clear, authoritative perspective for researchers navigating this complex topic

The key takeaways about glutathione IV versus oral supplementation center on bioavailability, safety profile, cost, and regulatory status

This guide answers all of these questions in simple, honest language

CDMOs are expanding oral solid dosage (OSD) capabilities to support anticipated demand

GLP-1s and Hormone Therapy For perimenopausal women already using hormone therapy and considering adding GLP-1s, its important to understand how GLP-1s and hormone therapy may interact